healthprotocol.wiki

saad_2002_rct_zoledronic-acid-4mg-vs-placebo-sre-mcrpc

4 findings

Protocol
medication-osteoporosis-zoledronic-acid-intravenous-every-three-week-dose-reduced-generic
Outcome
oncology-skeletal-related-event-occurrence-detected-binary-measured
n
221
effect
15
attribution
40
Protocol
medication-osteoporosis-zoledronic-acid-intravenous-every-three-week-generic
Outcome
oncology-skeletal-related-event-occurrence-detected-binary-measured
n
214
effect
45
attribution
80
Protocol
medication-osteoporosis-zoledronic-acid-intravenous-every-three-week-dose-reduced-generic
Outcome
oncology-skeletal-related-event-time-to-first-event-months-measured
n
221
effect
15
attribution
40
Protocol
medication-osteoporosis-zoledronic-acid-intravenous-every-three-week-generic
Outcome
oncology-skeletal-related-event-time-to-first-event-months-measured
n
214
effect
50
attribution
80